DRUG UTILIZATION PATTERN IN PAEDIATRIC PATIENTS IN A SECONDARY CARE HOSPITAL by SENTHILSELVI, R. et al.
 
Original Article 
DRUG UTILIZATION PATTERN IN PAEDIATRIC PATIENTS IN A SECONDARY CARE HOSPITAL 
 
R. SENTHILSELVI1*, M. BOOPANA1, LINTA SATHYAN1, PRIYA VISUVASAM2, V. GANESAN1 
1Department of Pharmacy Practice, The Erode College of Pharmacy, Erode, 638112, Tamilnadu, India, 2Govt. Head Quarters Hospital, 
Tiruppur, Tamilnadu, India 
Email: Senthilselvi65@gmail.com 
Received: 12 Nov 2018 Revised and Accepted: 22 Feb 2019 
ABSTRACT 
Objective: The study was carried out to generate research on drug utilization pattern in paediatric patients in government headquarters hospital, 
Tiruppur, Tamilnadu, India using world health organization (WHO) and international network for rational use of drugs (INRUD) core indicator. 
Methods: The core prescribing indicators of the world health organization was used to assess the appropriate use of drugs. Index of rational drug 
prescribing (IRDP) developed by Zhang and Zhi was also used to find out the performance of a health care system in terms of drug utilization. 
Results: Out of 859 drugs in 200 cases the highest prescribed drug class is antibiotics 304(35.39%) and the majority of drugs were administered in 
injectable form 412(47.94%). It was analysed that a majority of prescriptions 117(58.5%) were discharged in between 4-7 d. 161(80.5%) patients 
were dismissed after completion of treatment. On analysing world health organization (WHO) prescribing core indicators, the average number of 
drugs per prescription was 4.29 which is higher than double the average number (i.e., 2). This indicates poly-pharmacy practice. 97.78% of drugs 
were prescribed were the generic name and percentage of encounters with antibiotic prescribed was 90.5% which is thrice greater than world 
health organization (WHO) standard<30%. Prescribing of injections is not within the world health organization (WHO) recommended range<20% 
and it was far higher showing 97.5% which is essential for paediatric inpatients. The prescribing practice in paediatric ward is in complete 
adherence to national essential drug list (EDL) or formulary. The mean value of the index of rational drug prescribing (IRDP) obtained was 3.09 
which is very similar to that of optimal value world health organization (WHO). 
Conclusion: Prescription by generic name, prescribing drugs from essential drug list (EDL) and free government supply are encouraging findings in 
this hospital. The result shows poly-pharmacy and overuse of antibiotics are the areas to be concerned. The better clinical outcome shows rational 
prescribing is practised well. 
Keywords: Core indicators, an International network for rational use of drugs (INRUD), Index of Rational Drug Prescribing (IRDP), Poly-pharmacy, 
Essential drug list (EDL), Antibiotics 




World Health Organization (WHO) defined drug utilization research 
as ‘studies on the marketing, distribution, prescription and the use of 
drugs in a society, with special emphasis on the resulting medical, 
social and economic consequences [1, 2]. Drug utilization studies are 
important in order to evaluate the appropriate and judicious use of 
drug therapy [3]. Appropriate drug utilization studies are properly 
utilized to evaluate the efficacy, safety, convenience and economic 
aspects at all levels in the chain of drug use. 
Various drug utilization reviews have been conducted all over the 
world but only limited studies are conducted addressing the drug 
use pattern in paediatric population especially in India [4]. 20 to 
25% of total world population comprise paediatric, which are more 
prone to acute and chronic infectious disease. The incomplete 
development of paediatric physiological conditions and their rapid 
growth and development need some accurate diagnosis and 
evidence-based medical treatment [5]. 
Infants and children are the most vulnerable population groups. 
They are particularly sensitive to contract illness and harmful effects 
of drugs because of their difference in pharmacokinetics and 
pharmacodynamics to that of adults [6]. Also, drug use in paediatric 
is not extensively researched and the dosage form of licensed drugs 
is limited [7]. 
Monitoring the safety of medical use in children is of paramount 
importance because only a limited data can be generated through 
clinical trials of drug development [8]. Infants and children 
constitute a large population in a developing country like India. 
Promotion of appropriate and safe drugs for children is hour 
globally essential [9]. 
Doses for children often derived from adult dosages after adjusting the 
body weight. But even within the paediatric population especially 
preterm neonate doses varies from the calculated weight-adjusted 
doses [10]. There are likewise various drug-related problems in 
children such as heterogeneous nature of paediatric population, off-
label and unlicensed drug use, lack of familiarity between adult and 
paediatric guidelines, inability to swallow solid dosage form etc [11]. 
Prescription auditing, a type of vigilance activity, which is beneficial in 
clinical practice for reducing the burden of disease and to ensure 
irrational prescribing is hence indispensable [9]. 
MATERIALS AND METHODS 
Study site 
The study was conducted in the department of child health on 
Government district headquarters Hospital, Tiruppur, a 500 bedded 
hospital. 
Study design 
This is a prospective observational study and was carried out in the 
department of child health unit of Government Headquarters 
Hospital, Tiruppur. 
Study period 
The study was undertaken during a period of 6 mo from March 2018 
to August 2018. 
Study population 
The study population includes the patients of Govt. Headquarters 
Hospital, Tiruppur. A total of 200 numbers of admitted cases were 
chosen from paediatric ward. 
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Research protocol, data collection form and informed consent 
form (Tamil/English) was approved by the Institutional Human 
Ethics Committee (IHEC) of the Government Headquarters 
Hospital, Tiruppur, Tamilnadu (IHEC NO: IHEC/GH-
Tiruppur/ECP/PD-002). The approval was obtained before the 
study was commenced. 
Patient selection 
Patient’s selection was based on the inclusion criteria. The 
inclusion criteria included newborn of 1 mo to 12 y, considered 
both male and female patients who stayed in the hospital for more 
than 24 h. Exclusion criteria included all adult patients, 
outpatients, intensive care unit emergency patients, immuno-
compromised patients and the patients not willing to participate in 
the study.  
Prescribing core indicators 
The prescribing core indicators of WHO was an average number of 
medicines per encounter, percentage of medicines prescribed by generic 
name, percentage of encounters with an antibiotic prescribed, 
percentage of encounters with an injection prescribed and percentage of 
medicines prescribed  from the essential drug list formulary. 
Index of rational drug prescribing (IRDP) was also performed. 
Statistical analysis 
Data were entered and analysed using Microsoft Excel (windows 8; 
version 2007). Graphical representation is used for visual 
interpretation of the analysed data. 
RESULTS 
Out of 200 prescriptions analyzed, a total of 859 drugs were prescribed.
 
Table 1: Age-wise classification 
Age group Frequency Percentage (%) 
1-23 Mo 58 29 
2-11 Y 134 67 
12 Y 8 4 
 
Table 2: Gender wise distribution 
Age % of male % of female 
1-23 Mo 29 29 
2-11 Y 65 69 
12 Y 6 2 
 
Table 3: Distribution of diseases in paediatric patients 
Distribution of diseases No. of diseases Percentage (%) 
Seizure disorder 27 13.5 
GI disorder 35 17.5 
Fever 54 27 
Respiratory disease 46 23 
UTI 4 2 
Anaemia/Malnutrition 4 2 
Poison cases 14 7 
Genetic disorders 2 1 
Autoimmune disease 1 0.5 
Others 13 6.5 
 
Table 4: Medicines prescribed to paediatric patients 
Medicines category No. of drugs Percentage (%) 
Anti-asthmatics 57 6.64 
Anti allergics 43 5.0 
NSAIDS 159 18.5 
Anti-emetics 41 4.77 
Corticosteroids 5 0.58 
Anti-epileptics 42 4.88 
Antiulcer agents 82 9.54 
Antispasmodics 4 0.47 
Vaccines 3 0.34 
Anti-amoebic agents 14 1.63 
Vitamin supplements 10 1.16 
Antibiotics 304 35.39 
Others 95 11.1 
 
Table 5: Antibiotics prescribed to paediatrics 
Antibiotic classification No. of antibiotics Percentage (%) 
Aminoglycosides 83 27 
Cephalosporins 167 55 
Penicillin 22 7 
Penicillin combinations 11 3 
Macrolides 15 5 
Tetracyclines 2 1 
Sulphonamide combinations 2 1 
Carbapenem 2 1 
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Table 6: Route of administration 
ROA Sub-class Frequency Percentage (%) 
Injectables Intravenous 409 47.6 
Intramuscular 2 0.23 
Subcutaneous 1 0.11 
Oral - 384 44.7 
Inhale - 62 7.21 
Topical - 1 0.11 
 
Table 7: Drug-drug interaction per encounter 
Drug interaction No. of prescriptions Percentage (%) 
Cases with DI 126 63 
Cases without DI 74 37 
 
Table 8: Duration of hospital stay 
Duration No. of prescriptions Percentage (%) 
1-3 d 58 29 
4-7 d 117 58.5 
8-11 d 22 11 
12 or above 3 1.5 
 
Table 9: Patient outcomes 
Patient outcomes No. of patients Percentage (%) 
Discharged 161 80.5 
Referred 8 4 
Discharged at request 21 10.5 
Absconded/leave against medical advice (LAMA) 10 0.5 
 
 
Fig. 1: Age wise classification 
 
 
Fig. 2: Gender wise distribution
 
Fig. 3: Distribution of diseases 
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Table 10: Assessment of prescribing indicators 
Prescribing indicators assessed Average/percentage WHO standard 
Average number of drugs per encounter 4.29 ≤2 
Percentage of drugs prescribed by generic name 97.78% 100% 
Percentage of encounters with antibiotics 90.5% <30% 
Percentage of encounters with injections 97.5% <20% 
Percentage of drugs from essential drug list 100% 100% 
 
 
Fig. 4: Medicines prescribed to paediatrics 
 
 
Fig. 5: Antibiotics prescribed 
 
 
Fig. 6: Route of administration 
 
Senthilselvi et al. 




Fig. 7: Drug-drug interaction 
 
 
Fig. 8: Duration of hospital stay 
 
 
Fig. 9: Patient outcomes 
 
 
Fig. 10: WHO prescribing indicators 
 
DISCUSSION 
The paediatrics were considered to be infants and toddlers (1 mo-23 
mo), children (2-11 y) and adolescents (12 y) according to age group 
and also by considering inclusion criteria of this study. Adolescent 
patients are 8 (4%), found to be significantly less when compared to 
infants and toddlers 58 (29%) and children 134 (67%). 
The number of male patients (65%) and female patients (69%) was 
found to be significantly high in the age group 2-11 y (children) 
when compared to the number of male patients (6%) and female 
patients (2%) in the age group of 12 y (adolescents). An equal 
number of male and female patients (29%) was observed in the age 
group 1 mo — 23 mo (infants and toddlers). 
The majority of paediatric patients were taken to the hospital due to 
fever and it was 54 (27%). Second comes respiratory disease 46 
(23%). Gastrointestinal disorder was found to be 35 (17.5%) and 
then comes seizure disorder 27 (13.5%). Paediatric patients 
admitted with poisoning cases were 14 (7%) and with genetic 
disorder is 1 (0.5%). Paediatrics admitted due to urinary tract 
infection and anaemia/malnutrition were found to be equal 4 (2%). 
Only 1 (0.5%) is admitted due to autoimmune disease and 13 (6.5%) 
belong to other diseases. An earlier study reported that respiratory 
system disease (25.6%), was most commonly seen, followed by fever 
(19.2%), GIT (18.4%) and hepatitis (8.8%) disorders [6]. 
The highest prescribed drug class is antibiotics 304 (35.39%). 
Second commonly prescribed drugs belong to nonsteroidal anti-
inflammatory drugs (NSAIDs) 159 (18.5%). 57 (6.64%) number of 
drugs prescribed are anti-asthmatics, 43 (5%) are anti-allergic, 41 
(4.77%) are antiemetic, 5 (0.58%) are corticosteroids, 42 (4.88%) 
number of drugs belong to anti-epileptic, 82 (9.54%) are anti-ulcer 
agents, 14 (1.63%) are anti-amoebic agents, 10 (1.16%) are vitamin 
supplements and 4 (0.47%) are antispasmodic. The least prescribed 
drugs are vaccines 3 (0.34%). The rest of drugs 95 (11.1%) are 
categorized as others. A previous study reported that analgesic 
drugs were the most frequently prescribed therapeutic class of 
drugs (26.9%) [12]. 
Among antibiotics, cephalosporin 167(55%) are the most prescribed 
and then comes aminoglycosides 83 (27%). 22 (7%) number of 
drugs is penicillin, 15 (5%) are macrolides and 11 (3%) are 
penicillin combinations. Equal number of drugs 2 (1%) are 
prescribed as tetracyclines, carbapenem and sulphonamide 
combinations. In a study, it was found that the most frequently 
prescribed group of antibacterial were cephalosporin (62%) 
followed by penicillin [13]. 
The majority of drugs were administered in injectable form 412 
(47.94%), in which the intravenous route is most commonly 
administered 409 (47.6%). Only 2 (0.23%) of drugs are 
administered via intramuscular route and 1 (0.11%) is given via 
subcutaneous route. Oral route is contributing around 384 (44.7%). 
Inhalation route contributes around 62 (7.21%) and topical was 
only 1 (0.11%). In another study it was found that 85.6% of 
medications are oral medications, 4.4% of cases consist of 
inhalational drugs, 8.6% of cases are topical drugs and 1.3% are 
suppositories or pessesaries [14].  
27 (13.5%) number of prescriptions was found to be there with drug 
duplication and the remaining 173 (86.5%) were identified as cases 
without drug duplication as per drugs. com website. 126 (63%) 
prescriptions are cases with drug interaction and 73 (37%) number 
of prescriptions are found to be without drug interactions.141 
(72.31) number of moderate drug interactions and 54(27.69%) 
number of minor drug interactions were found by analysing the 
prescription. Major drug interactions are not reported in case drug-
food interaction 184 (92%) prescriptions have no drug-food 
interactions and only 16 (8%) number of prescriptions have 
reported drug-food interactions. Utilizing drugs. com website it was 
determined that 155 (77.5%) numbers are cases without 
contraindications and 45 (22.5%) are cases with contraindications. 
While considering the comorbidity 69 (34.5%) prescriptions out of 
200 are having 1 comorbidity, 9(4.5%) are prescriptions with 2 co 
morbidity and only 2 (1%) are prescriptions with ≥ 3 comorbidity. 
Majority of the prescriptions 117 (58.5%) show a duration of 
hospital stay for 4-7 d, 58 (29%) number of patients stayed in the 
hospital for 1-3 d, 22 (11%) number of patients were stayed for a 
period of 8-11 d and 3 (1.5%) patients were stayed for 12 or more 
days. 161 (80.5%) number of patients were discharged after 
completion of treatment and 8 (4%) were referred for better 
treatment. 21 (10.5%) were discharged at the request and 10 (5%) 
were absconded during the study. 
An average number of drugs per prescription were 4.29 which is 
greater than double the average number (i.e., 2) recommended by the 
world health organisation (WHO). The increased value indicates the 
poly-pharmacy practice in this hospital. However, this cannot be 
considered irrational poly-pharmacy practice as there is need of 
empirical therapy till definitive diagnosis becomes clear and secondly 
for management of acute-life threatening conditions. Most of the 
patients require two or more drugs and here 52 (26%) patients have 
received 5 drugs during the hospital stay, which is the highest. 
The percentage of drugs prescribed by generic (international non-
proprietary) name is 97.78 in this study but according to WHO 
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standards the optimal value is 100%. By using the generic name in 
the prescriptions, the chance of duplication of drug products can be 
avoided. Example: the prescribing of albuterol and duolin 
(levalbuterol/ipratropium) at a time. 
Percentage of encounters with an antibiotic prescribed was 90.5% 
which is thrice greater than WHO standard<30%. This indicates an 
increased use of antibiotics in paediatric population. However, the 
increased use of antibiotics in paediatrics is caused by severe 
infections, prophylactic treatment for infections and for doubtful 
secondary bacterial infections in viral diseases. The lack of proper or 
definitive diagnosis is also a reason for increased antibiotic use. 
Prescribing of injections is not within the WHO recommended 
range<20% and it was far higher showing 97.5%. However, this 
increased prescribing of injection is not irrational as the 
recommended range is for outpatients. Due to the severity of illness, 
unavailability of oral and other dosage forms for a particular drug 
and to increase medication adherence injection formulation may be 
prescribed more. Nevertheless, the overuse of injections may lead to 
economic cost and health hazards. In a previous study it was found 
that average number of drugs per prescription as 4 and percentage 
of drugs prescribed by generic name as 45%. The percentage of 
antibiotics prescribed was 33% and percentage of encounters with 
an injection in that study was 30.6% [6]. 
In this study, it was found that the prescribing practice in paediatric 
ward is in complete adherence to national essential drug list/formulary. 
The mean value of Index of Rational Drug Prescribing (IRDP) was 
3.09 which are very close to WHO optimal value of 5. The optimal 
index for all indicators was fixed at 1. Values closer to 1indicates the 
rational drug use. 
CONCLUSION 
This study demonstrates that prescription by generic name and 
prescribing drugs from EDL and free government supply of health 
care is encouraging findings. Poly-pharmacy and overuse of 
antibiotics are the areas to worry. Prescribing antibiotics to 
paediatric patients based on empirical therapy without culture 
sensitive test may lead to antibiotic resistance and health issues in 
the future. 
It is rational to choose the intravenous route in the paediatric 
patient with age less than 14, who are admitted and who are in need 
of emergency care. Hence, prescribing of injections is not within the 
WHO recommend range<20%. 
Sticking to state standard treatment guidelines in the light of 
WHO/INRUD for paediatrics and awareness among paediatricians 
will promote more rational prescribing. 
LIMITATION OF THE STUDY  
The study was conducted in a hospital in a rural area and only 200 
paediatrics have participated in the study. As a result, we could not 
have a large sample size which could increase our work significance. 
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